OreStocks

Albemarle Corporation press release

Albemarle Reports Second Quarter 2026 Results

NYSE - New York Stock Exchange · Lithium · Kaolin · Potash · Sodium · Bromine · Sulfur · Aluminium · Magnesium · Nickel · Cobalt · United States · Corporate Finance

PR Newswire

CHARLOTTE, N.C., Aug. 5, 2026/PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2026.

Second Quarter 2026 and Recent Highlights (Unless otherwise stated, all percentage changes represent year-over-year comparisons and do not exclude the prior-period results of Ketjen's refining catalyst solutions business in which the company sold a 51% stake on March 2, 2026)

Net sales of $1.7 billion, up 31% due to higher pricing in Energy Storage (+73%) and higher pricing and volumes in Specialties (price +11%, volume +8%). Net income of $480 million, or $3.52 per diluted share attributable to common shareholders. Adjusted EBITDA(a)of $858 million; up 155% due primarily to higher pricing in Energy Storage, increased pricing and volumes in Specialties and ongoing cost and productivity improvements. Adjusted EBITDA expanded in both Energy Storage (+229%) and Specialties (+61%). Cash from operating activities of $710 million and free cash flow of $638 million(a). Operating cash flow conversion of 83%(a), primarily driven by timing of an increased dividend from the Talison joint venture and non-recurring working capital benefits. Delivered $100 million in year-to-date run-rate cost and productivity improvements, tracking towards the high end of our full-year target of $100 to $150 million. Improving full-year 2026 outlook considerations including: Increasing full-year Specialties net sales outlook to $1.4 to $1.6 billion and adjusted EBITDA outlook to $275 to $325 million, due to stronger-than-expected pricing and volume performance year to date. Expect minimal impact to Energy Storage sales volume related to the fire at Talison CGP3 which occurred on June 9, in part due to better-than-planned output from the Wodgina mine. Reducing full-year capital expenditure forecast to approximately $500 million due to ongoing capital efficiency improvements.

| (a) See Non-GAAP Reconciliations for further details. |

"Albemarle delivered another quarter of strong results, reflecting improved pricing, continued strength in Specialties, disciplined cost and productivity execution, and strong cash generation," said Kent Masters, Chairman and CEO. "We continue to see resilient demand fundamentals across our core markets, including energy storage, electric vehicles, and semiconductors. We are advancing our highest value organic growth opportunities while maintaining a disciplined approach to capital allocation and execution."

| Second Quarter 2026 Results | | | | | | | | | In millions, except per share amounts | Q2 2026 | | Q2 2025 | | $ Change | | % Change | | Net sales | $ 1,743.3 | | $ 1,330.0 | | $ 413.3 | | 31.1 % | | Net income attributable to Albemarle Corporation | $ 480.0 | | $ 22.9 | | $ 457.1 | | 1,996.2 % | | Adjusted EBITDA(a) | $ 858.1 | | $ 336.5 | | $ 521.6 | | 155.0 % | | Diluted income (loss) per share attributable to common shareholders | $ 3.52 | | $ (0.16) | | $ 3.68 | | NM | | Non-recurring and other unusual items(a) | 0.22 | | 0.27 | | | | | | Adjusted diluted income per share attributable to common shareholders(a)(b) | $ 3.75 | | $ 0.11 | | $ 3.64 | | NM | | | | | | | | | | | (a) See Non-GAAP Reconciliations for further details.

(b) Totals may not add due to rounding. | | | | | | | |

Net sales for the second quarter of 2026 were $1.7 billion compared to $1.3 billion for the prior-year quarter, up 31%, driven primarily by higher prices in both Energy Storage and Specialties and volume growth in Specialties. Adjusted EBITDA of $858 million increased by $522 million from the prior-year quarter, primarily due to higher net sales and ongoing cost and productivity improvements.

Net income attributable to Albemarle of $480 million increased year over year by $457 million. The effective income tax rate for the second quarter of 2026 was 21.3% or 19.1% on an adjusted basis.

| Energy Storage Results | | | | | | | | | In millions | Q2 2026 | | Q2 2025 | | $ Change | | % Change | | Net Sales | $ 1,276.7 | | $ 717.7 | | $ 559.0 | | 77.9 % | | Sales Volume (kT LCE)(a) | 65 | | 59 | | 6 | | 11.0 % | | Avg. Realized Price ($/kg LCE)(a) | $ 19.53 | | $ 12.17 | | $ 7.36 | | 60.5 % | | Adjusted EBITDA | $ 723.5 | | $ 219.7 | | $ 503.7 | | 229.3 % | | | | | | | | | | | (a) Includes aggregated salts and spodumene sales on a lithium carbonate equivalent (LCE) basis. | | | | | | | |

Energy Storage net sales for the second quarter of 2026 were $1.3 billion, an increase of $559 million, or 78%, due to higher pricing. Adjusted EBITDA of $723 million increased $504 million, or 229%, primarily due to higher lithium pricing partially offset by higher CORFO commissions.

| Specialties Results | | | | | | | | | In millions | Q2 2026 | | Q2 2025 | | $ Change | | % Change | | Net Sales | $ 423.5 | | $ 351.6 | | $ 71.9 | | 20.5 % | | Adjusted EBITDA | $ 117.7 | | $ 73.0 | | $ 44.7 | | 61.3 % |

Specialties net sales for the second quarter of 2026 were $423 million, an increase of $72 million, or 20%, primarily due to higher volumes (+8%) and pricing (+11%). Adjusted EBITDA of $118 million increased $45 million, or 61%, primarily due to higher volumes and favorable pricing in bromine and derivatives, along with continued productivity improvements and proactive management of cost escalations driven by the conflict in the Middle East.

2026 Outlook Considerations

Total Corporate Outlook Considerations The table below reflects expected outcomes for the total company based on recently observed lithium market price scenarios. Outlook ranges for each scenario are based on variation in sales volume and product mix. Energy Storage production volumes are expected to increase year over year. Sales volumes are expected to be in the range of 225 to 235 kilotons lithium carbonate equivalent, as increased Wodgina volumes partially offset a delay in the Talison CGP3 ramp due to a fire that occurred on June 9. All three scenarios assume flat market pricing flowing through Energy Storage's current contract book which includes approximately 40% of salts volume (or one-third of total volumes) on long-term agreements. Scenarios also assume that spodumene pricing averages 10% of the lithium carbonate equivalent (LCE) price, while other costs are assumed to be constant.

| | Total Corporate FY 2026E | | | | Observed market price case(a) | FY 2025 avg. | Q1 2026 avg. | 2021-2025 avg. | | Average lithium market price ($/kg LCE)(a) | ~$10 | ~$20 | ~$30 | | Net sales | $4.1 - $4.3 billion | $5.7 - $6.0 billion | $7.5 - $7.8 billion | | Adjusted EBITDA(b) | $0.9 - $1.0 billion | $2.4 - $2.6 billion | $4.2 - $4.4 billion | | | | | | | (a) Price represents blend of relevant market pricing including spot and regional indices for the periods referenced.

(b) The Company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. See "Additional Information Regarding Non-GAAP Measures" for more information. | | | |

| Energy Storage Market Price Scenarios | | | | | | Energy Storage FY 2026E | | | | Observed market price case(a) | FY 2025 avg. | Q1 2026 avg. | 2021-2025 avg. | | Average lithium market price ($/kg LCE)(a) | ~$10 | ~$20 | ~$30 | | Net sales | $2.5 - $2.6 billion | $4.0 - $4.2 billion | $5.9 - $6.1 billion | | Adjusted EBITDA | $0.7 - $0.8 billion | $2.1 - $2.3 billion | $3.9 - $4.1 billion | | Equity in net income of unconsolidated investments (net of tax)(b) | $0.2 - $0.3 billion | $0.6 - $0.7 billion | $1.0 - $1.1 billion | | | | | | | (a) Price represents blend of relevant market pricing including spot and regional indices for the periods referenced.

(b) Included in adjusted EBITDA on a pre-tax basis. | | | |

Specialties Outlook Considerations Specialties net sales and adjusted EBITDA outlook is improved primarily due to strong year to date performance driven by volume growth in bromine specialties and cost and productivity improvements. Our outlook continues to reflect modest volume growth in key end markets led by semiconductors, oil and gas, flame retardants and pharmaceuticals partially offset by expected softness in automotive and petrochemicals. Second-half outlook assumes stabilization in the bromine market and continued uncertainties including the situation in the Middle East. Operations at the Jordan Bromine Company (JBC) joint venture are in line with expectations as it continues to navigate geopolitical tensions in the region.

| | Segment FY 2026E | | Specialties net sales | $1.4 - $1.6 billion | | Specialties adjusted EBITDA | $275 - $325 million |

Other Corporate Outlook Considerations Albemarle expects its full-year 2026 capital expenditures to be approximately $500 million, down 15% compared to 2025 due to ongoing capital efficiency improvements.

Following the sale of a controlling stake in Ketjen's refining catalyst solutions business, announced on March 2, 2026, the refining catalyst business earnings are now classified as equity income and included in Corporate, as are the results of the retained Performance Catalyst Solutions (PCS) business. The adjusted EBITDA and equity income contributions from these are expected to be immaterial post transaction.

Interest and financing expense is expected to be between $120 and $140 million for 2026 following the debt reduction actions completed in the first quarter of 2026.

| | Other Corporate FY 2026E | | Capital expenditures | ~$500 million | | Depreciation and amortization | $660 - $680 million | | Adjusted effective tax rate(a) | (50)% - 30% | | Corporate adjusted EBITDA (incl. FX, Ketjen equity income & PCS) | ($20) - $20 million | | Interest and financing expenses | $120 - $140 million | | Weighted-average common shares outstanding (diluted)(b) | ~136 million | | | | | (a) Adjusted effective tax rate dependent on lithium market prices and geographic income mix

(b) Diluted weighted-average common shares outstanding amount assumes the conversion of preferred stock and the net income attributable to common shareholders will not be reduced by mandatory convertible preferred stock dividends. If the reduction of mandatory convertible preferred stock dividends results in a more dilutive earnings per share, the diluted weighted-average common shares outstanding will not assume conversion of the preferred stock. | |

Cash Flow and Capital Deployment Cash from operations of $1.1 billion in the first half of 2026 increased $518 million compared to the prior-year period. Capital expenditures of $170 million in the first six months of 2026 decreased by $132 million versus the prior-year period.

Balance Sheet and Liquidity As of June 30, 2026, Albemarle had estimated liquidity of approximately $3.2 billion, including $1.6 billion of cash and cash equivalents, $1.5 billion available under our revolver and $78 million available under other credit lines. Total debt was $1.9 billion, representing a net debt to adjusted EBITDA ratio (as defined in our credit agreement) of approximately 0.5(a).

| (a) See Non-GAAP Reconciliations for further details. |

Earnings Call

| Date: | Thurs., August 6, 2026 | | Time: | 8:00 AM Eastern time | | Dial-in (U.S.): | 1-800-590-8290 | | Dial-in (International): | 1-240-690-8800 | | Conference ID: | ALBQ2 |

The company's earnings presentation and supporting material are available on Albemarle's website at https://investors.albemarle.com.

About Albemarle Albemarle Corporation (NYSE: ALB) is a world leader in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers. Learn more about how the people of Albemarle are enabling a more resilient world at Albemarle.com.

Albemarle regularly posts information to Albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, U.S. Securities and Exchange Commission filings and other information regarding the company, its businesses and the markets it serves.

Forward-Looking Statements This press release contains statements concerning our expectations, anticipations and beliefs regarding the future, which constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties, often contain words such as "ambition," "anticipate," "believe," "estimate," "expect," "goal," "guidance," "intend," "may," "outlook," "scenario," "should," "would," and "will." Forward-looking statements may include statements regarding: our 2026 company and segment outlooks, including expected market pricing of lithium carbonate equivalent and spodumene and other underlying assumptions and outlook consideration; plans and expectations regarding customer demand and sales; production impacts; financial flexibility and optionality; expected or actual market pricing of lithium, spodumene, bromine, and lithium specialties ("Company Products"); supply and demand for Company Products; drivers of long-term demand and growth; other underlying assumptions and outlook considerations; expected capital allocation and expenditure amounts and the corresponding impact on cash flow; expected impact of tariffs and other trade restrictions; plans and expectations regarding other mining interests, resources, reserves, projects and activities, compound annual growth rate, cost reductions, conversion network optimization, margin improvement, accounting charges, and all other information relating to matters that are not historical facts. Factors that could cause Albemarle's actual results to differ materially from the outlook expressed or implied in any forward-looking statement include: changes in economic and business conditions; changes in trade policies and tariffs; and the financial and operating performance of customers; timing and magnitude of customer orders; fluctuations in market pricing of lithium carbonate equivalent and spodumene; potential production volume shortfalls; increased competition and pressure to renegotiate contract terms; changes in product or conversion demand; availability and cost of raw materials and energy; technological change and development; fluctuations in foreign currencies; changes in laws and government regulation; regulatory actions, proceedings, claims or litigation; cyber-security breaches, terrorist attacks, industrial accidents or natural disasters; risks related to the integration of artificial intelligence technologies into our operations; geopolitical conflicts and political unrest affecting global trade, including tensions in the Middle East; the global economy and clean energy initiatives; our ability to retain key personnel and attract new skilled personnel changes in inflation or interest rates; volatility and uncertainties in the debt and equity markets; acquisition and divestiture transactions; timing and success of projects; expected benefits and expenses from new operating structure and asset optimization activities; performance of Albemarle's partners in joint ventures and other projects; changes in credit ratings; and the other factors detailed from time to time in the reports Albemarle files with the SEC, including those described under "Risk Factors" in Albemarle's most recent Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q, which are filed with the SEC and available on the investor section of Albemarle's website (investors.albemarle.com) and on the SEC's website at www.sec.gov. These forward-looking statements speak only as of the date of this press release. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

| Albemarle Corporation and Subsidiaries

Consolidated Statements of Income

(In Thousands Except Per Share Amounts) (Unaudited) | | | | | | | | | | Three Months Ended | | Six Months Ended | | | | | | | June 30, | | June 30, | | | | | | | 2026 | | 2025 | | 2026 | | 2025 | | Net sales | $ 1,743,313 | | $ 1,329,992 | | $ 3,172,044 | | $ 2,406,873 | | Cost of goods sold | 1,153,012 | | 1,133,116 | | 2,080,777 | | 2,053,698 | | Gross profit | 590,301 | | 196,876 | | 1,091,267 | | 353,175 | | Selling, general and administrative expenses | 126,353 | | 132,457 | | 263,759 | | 255,959 | | Restructuring charges and asset write-offs | 7,337 | | 4,448 | | 33,203 | | 3,385 | | Research and development expenses | 3,667 | | 12,444 | | 12,837 | | 26,543 | | Loss on sale of business | — | | — | | 95,018 | | — | | Operating income | 452,944 | | 47,527 | | 686,450 | | 67,288 | | Interest and financing expenses | (30,924) | | (49,939) | | (64,045) | | (98,916) | | Other income (expenses), net | 19,629 | | (6,559) | | 73,439 | | 3,691 | | Income (loss) before income taxes and equity in net income of unconsolidated investments | 441,649 | | (8,971) | | 695,844 | | (27,937) | | Income tax expense | 94,002 | | 34,094 | | 115,513 | | 30,116 | | Income (loss) before equity in net income of unconsolidated investments | 347,647 | | (43,065) | | 580,331 | | (58,053) | | Equity in net income of unconsolidated investments (net of tax) | 151,564 | | 78,258 | | 247,857 | | 142,544 | | Net income | 499,211 | | 35,193 | | 828,188 | | 84,491 | | Net income attributable to noncontrolling interests | (19,252) | | (12,296) | | (29,138) | | (20,246) | | Net income attributable to Albemarle Corporation | 479,959 | | 22,897 | | 799,050 | | 64,245 | | Mandatory convertible preferred stock dividends | (41,687) | | (41,687) | | (83,375) | | (83,375) | | Net income (loss) attributable to Albemarle Corporation common shareholders | $ 438,272 | | $ (18,790) | | $ 715,675 | | $ (19,130) | | Basic earnings (loss) per share attributable to common shareholders | $ 3.72 | | $ (0.16) | | $ 6.07 | | $ (0.16) | | Diluted earnings (loss) per share attributable to common shareholders | $ 3.52 | | $ (0.16) | | $ 5.87 | | $ (0.16) | | | | | | | | | | | Weighted-average common shares outstanding – basic | 117,961 | | 117,665 | | 117,907 | | 117,634 | | Weighted-average common shares outstanding – diluted | 136,212 | | 117,665 | | 136,170 | | 117,634 |

| Albemarle Corporation and Subsidiaries

Condensed Consolidated Balance Sheets

(In Thousands) (Unaudited) | | | | | | June 30, | | December 31, | | | 2026 | | 2025 | | ASSETS | | | | | Current assets: | | | | | Cash and cash equivalents | $ 1,631,688 | | $ 1,618,001 | | Trade accounts receivable | 603,805 | | 593,502 | | Other accounts receivable | 123,870 | | 105,110 | | Inventories | 1,384,563 | | 1,179,271 | | Other current assets | 200,275 | | 140,440 | | Current assets held for sale | — | | 371,815 | | Total current assets | 3,944,201 | | 4,008,139 | | Property, plant and equipment | 11,902,156 | | 11,768,840 | | Less accumulated depreciation and amortization | 3,442,831 | | 3,156,429 | | Net property, plant and equipment | 8,459,325 | | 8,612,411 | | Investments | 1,109,241 | | 900,926 | | Other assets | 707,577 | | 647,185 | | Goodwill | 1,482,672 | | 1,499,657 | | Other intangibles, net of amortization | 202,079 | | 214,233 | | Noncurrent assets held for sale | — | | 491,660 | | Total assets | $ 15,905,095 | | $ 16,374,211 | | LIABILITIES AND EQUITY | | | | | Current liabilities: | | | | | Accounts payable to third parties | $ 670,229 | | $ 779,160 | | Accounts payable to related parties | 445,421 | | 134,369 | | Accrued expenses | 507,556 | | 521,831 | | Current portion of long-term debt | 74,677 | | 74,077 | | Dividends payable | 61,514 | | 61,387 | | Income taxes payable | 131,703 | | 35,467 | | Current liabilities held for sale | — | | 191,753 | | Total current liabilities | 1,891,100 | | 1,798,044 | | Long-term debt | 1,802,107 | | 3,119,464 | | Postretirement benefits | 45,198 | | 44,744 | | Pension benefits | 105,729 | | 117,361 | | Other noncurrent liabilities | 1,158,555 | | 1,084,892 | | Deferred income taxes | 368,552 | | 368,275 | | Noncurrent liabilities held for sale | — | | 59,970 | | Commitments and contingencies | | | | | Equity: | | | | | Albemarle Corporation shareholders' equity: | | | | | Common stock | 1,180 | | 1,178 | | Mandatory convertible preferred stock | 2,235,105 | | 2,235,105 | | Additional paid-in capital | 3,048,664 | | 3,018,213 | | Accumulated other comprehensive loss | (243,599) | | (334,807) | | Retained earnings | 5,233,819 | | 4,613,676 | | Total Albemarle Corporation shareholders' equity | 10,275,169 | | 9,533,365 | | Noncontrolling interests | 258,685 | | 248,096 | | Total equity | 10,533,854 | | 9,781,461 | | Total liabilities and equity | $ 15,905,095 | | $ 16,374,211 |

Earlier from Albemarle Corporation

More corporate finance releases